48,535
edits
Difference between revisions of "Fibroblastic/myofibroblastic tumours"
Jump to navigation
Jump to search
Fibroblastic/myofibroblastic tumours (view source)
Revision as of 19:26, 6 November 2013
, 19:26, 6 November 2013→IHC
(→IHC) |
|||
| Line 173: | Line 173: | ||
*Beta-catenin +ve (nuclear<ref name=pmid23020601/>) - '''important'''. | *Beta-catenin +ve (nuclear<ref name=pmid23020601/>) - '''important'''. | ||
*SMA +ve ~50% of lesions. | *SMA +ve ~50% of lesions. | ||
*CD117 -ve. | |||
==Lipofibromatosis== | ==Lipofibromatosis== | ||